SB-200646 - CAS 143797-63-1
SB-200646 (CAT: I015594) is the first selective antagonist of the 5-HT2B and 5-HT2C receptors, with a higher affinity for these receptor subtypes compared to the 5-HT2A receptor. This selectivity allows SB-200646 to selectively block the actions of serotonin (5-HT) on the 5-HT2B and 5-HT2C receptors while sparing the 5-HT2A receptor. By antagonizing the 5-HT2B and 5-HT2C receptors, SB-200646 can modulate the effects of serotonin in various physiological processes and potentially provide therapeutic benefits.
* For research use only. Not for human or veterinary use.